Correlation Between Processa Pharmaceuticals and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Processa Pharmaceuticals and Unicycive Therapeutics, you can compare the effects of market volatilities on Processa Pharmaceuticals and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and Unicycive Therapeutics.
Diversification Opportunities for Processa Pharmaceuticals and Unicycive Therapeutics
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Processa and Unicycive is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between Processa Pharmaceuticals and Unicycive Therapeutics
Given the investment horizon of 90 days Processa Pharmaceuticals is expected to under-perform the Unicycive Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Processa Pharmaceuticals is 1.71 times less risky than Unicycive Therapeutics. The stock trades about -0.1 of its potential returns per unit of risk. The Unicycive Therapeutics is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 38.00 in Unicycive Therapeutics on June 24, 2024 and sell it today you would earn a total of 8.00 from holding Unicycive Therapeutics or generate 21.05% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Processa Pharmaceuticals vs. Unicycive Therapeutics
Performance |
Timeline |
Processa Pharmaceuticals |
Unicycive Therapeutics |
Processa Pharmaceuticals and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Processa Pharmaceuticals and Unicycive Therapeutics
The main advantage of trading using opposite Processa Pharmaceuticals and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.Processa Pharmaceuticals vs. HCW Biologics | Processa Pharmaceuticals vs. RenovoRx | Processa Pharmaceuticals vs. Scpharmaceuticals | Processa Pharmaceuticals vs. Milestone Pharmaceuticals |
Unicycive Therapeutics vs. HCW Biologics | Unicycive Therapeutics vs. RenovoRx | Unicycive Therapeutics vs. Scpharmaceuticals | Unicycive Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |